Pre-Employment THC Positive Tests Jumped 683% After California Legalization

THC-COOH positivity rate increased from 0.12% in 2017 to 0.94% in 2022 (Cochran-Armitage Z=5.19, p<0.001), a 683% relative increase. Among positive cases, 76% were aged 20-39 (mean: 29 years). The female proportion of positive cases rose dramatically from 25% to 62.2%. Median THC-COOH levels ranged from 60 to 176.5 ng/mL.

Retrospective analysis of 21,546 de-identified pre-employment urine drug screenings from 2017-2022 at a university-based hospital occupational medicine clinic. Initial immunoassay screening (50 ng/mL cutoff) followed by GC-MS confirmation (15 ng/mL). Cochran-Armitage trend test assessed temporal trends.

Pre-employment drug testing policies were designed when cannabis was illegal everywhere. As legalization spreads, the sharp increase in positive tests raises questions about whether cannabis testing should remain part of employment screening, especially since urine tests detect past use rather than impairment.

California's Assembly Bill 2188 (2024) restricts employers from using cannabis urine testing in hiring decisions, recognizing that these tests detect past use rather than current impairment. This study provides the empirical backdrop for that legislative shift, showing that positive rates increased substantially after legalization while the overall rate remained under 1%.

Single clinic at one hospital system. Cannot determine if positive results reflected increased cannabis use or decreased abstinence before testing. Missing demographic data for the total screening population limits subgroup analysis. Low overall positivity rate means small absolute numbers of positive cases.